期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Towards quality controllable strategies in wire-arc directed energy deposition 被引量:1
1
作者 Hanqi Gao Hengrui Li +7 位作者 Dandan Shao Naiwen Fang Yugang Miao Zengxi Pan Huijun Li Bo Zhang Zhike Peng Bintao Wu 《International Journal of Extreme Manufacturing》 2025年第4期78-109,共32页
Wire-arc directed energy deposition(wire-arc DED)enables the fabrication of large-scale metal components with rapid manufacturing ability and diverse material selection,making it a compelling technology in industries ... Wire-arc directed energy deposition(wire-arc DED)enables the fabrication of large-scale metal components with rapid manufacturing ability and diverse material selection,making it a compelling technology in industries and defenses.However,challenges in both macroscale and microscale defects still limit printed component widespread applications.Recent advances in automatic and intelligent technologies have brought a range of quality controllable strategies to the forefront.This review covers these new strategies for the printing component,including path planning,process monitoring,auxiliary processes,and post processing,while discussing the expectation for structure and quality improvement.In addition,the work brings new areas of intelligent wire-arc DED development,including advances in digital twin,visualization,and human-processing interaction to promote its performance.It is anticipated that a focus on intelligent system will be key to smart and high-quality manufacturing for future wire-arc DED. 展开更多
关键词 wire-arc DED current challenges quality control strategies intelligent fabrication technology
在线阅读 下载PDF
MHC-2D LC STRATEGY FOR THE HOLISTIC QUALITY CONTROL OF NOTOGINSENG-CONTAINING CHINESE PATENT MEDICINES
2
作者 Wan-Ying Wu 《World Journal of Traditional Chinese Medicine》 2015年第4期65-66,共2页
Current China Pharmacopoeia(ChP)standards employ diversified and case-dependent assay methods to evaluate the quality of different Chinese patent medicines(CPM)that contain Panax notoginseng as the monarch drug.These ... Current China Pharmacopoeia(ChP)standards employ diversified and case-dependent assay methods to evaluate the quality of different Chinese patent medicines(CPM)that contain Panax notoginseng as the monarch drug.These conventional HPLC-based approaches utilizing complex sample preparation procedure can easily result in low analytical efficiency and possible component loss.We thereby propose a'monomethodheterotrait matrix'(MHM) 展开更多
关键词 MHC-2D LC strategy FOR THE HOLISTIC quality control OF NOTOGINSENG-CONTAINING CHINESE PATENT MEDICINES LC
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部